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A comparison of different management techniques
for myocardial protection in acyanotic congenital
cardiac patients
Aim: It has already been shown that terminal warm blood cardioplegia (TWBC) supports myocardial
protection in pediatric patients when it is administered after cold blood cardioplegia. However, the
myocardial protective effects of TWBC applied after cold crystalloid cardioplegia (CCC) is still a
subject of debate.
Materials and methods: Twenty acyanotic congenital cardiac patients were randomly divided into
2 groups of 10. In the control group (CG), moderate hypothermia, topical cooling, and cold
crystalloid cardioplegia were performed for the protection of the myocardium. In the other group
(TWBCG), the same procedure was supported using TWBC just before the unclamping of the aorta.
Blood samples were analyzed to discover the progression of anaerobic energy metabolism potentially
causing injury of the myocardium during the ischemic, reperfusion, and postoperative period.
Results: There were no significant statistical differences in age, body weight, mean pulmonary artery
pressure, operation procedure, cardiopulmonary bypass and aortic cross clamping time, period of
respiratory support, and intensive care unit and hospital stay. Also measurement of serum cardiac
troponin T (TnT), creatine kinase MB(CK-MB), and lactate levels preoperatively, just after the release
of the cross clamp and at the time of postoperative 4, 12, 24, and 48 h showed no significant
differences either.
Conclusion: TWBC was not able to enhance the myocardial protective effects in acyanotic congenital
cardiac patients when performed in addition to CCC.
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Asiyanotik konjenital kalp hastalarında farklı myokard koruma
tekniklerinin karşılaştırılması
Amaç: Sıcak kan kardiyoplejisinin soğuk kan kardioplejisini takiben uygulanmasının çocuk
hastalarda myokardın korunmasını desteklediği zaten gösterilmiştir. Ancak sıcak kan
kardiyoplejisinin soğuk kristaloid kardiyopleji sonrası kullanıldığındaki myokardiyal koruyucu etkisi
hala tartışmalıdır.
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Yöntem ve gereç: 20 asiyanotik konjenital kalp hastası her iki grupta da 10 hasta olacak şekilde
rastgele olarak ikiye bölündü. Kontrol grubunda myokard koruması için orta hipotermi, topikal
soğutma ve soğuk kristaloid kardiopleji uygulandı. Diğer grupta ise aynı prosedür kros klemp
kalkmadan hemen önce terminal sıcak kan kardioplejisi verilerek desteklendi. Kan örnekleri iskemik,
reperfüzyon ve post-operatif dönemde hasara neden olan anaerobik enerji metabolizmasının
ilerleyişini tespit edebilmek için analiz edildi.
Bulgular: Yaş, ağırlık, ortalama pulmoner arter basıncı, operasyon prosedürü, kardiopulmoner
bypass ve aortik kros klemp süresi, respirator destek süresi ile yoğun bakım ve hastanede kalış
sürelerinde belirgin bir istatistiksel farklılık yoktu. Ayrıca Troponin T, Kreatinin Kinaz MB ve Laktat
serum düzeylerinin preoperatif, kros klemp kaldırıldıktan hemen sonra ve post-operatif 4, 12, 24 ve
48. saatlerdeki ölçümlerinde de belirgin bir istatistiksel farklılık saptanmadı.
Sonuç: Terminal sıcak kan kardioplejisi, asiyanotik konjenital kalp hastalarında soğuk kristaloid
kardiopleji ile birlikte kullanıldığında myokardiyal koruyucu etkileri arttırmakta yeterli olamamıştır.
Anahtar sözcükler: Myokardiyal koruma, terminal sıcak kan kardiopleji, soğuk kristaloid kardiopleji
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Introduction
To discover the most appropriate means of
myocardial protection is one of the most desirable
points of cardiac surgery, whether in adult or pediatric
patients. To protect the myocardium from ischemia is
as important as to be able to perform a successful
surgical correction.
Inadequate myocardial protection procedures are
responsible for most of the morbidity and mortality
complications in congenital cardiac patients (1).
The reduction of the metabolic activity and the
therapeutic arrest of the contractile apparatus are the
main principles of myocardial protection (2).
Hypothermia was regarded as an indispensable step
for myocardial protection until the 1950s, after
Bigelow pointed out the decrease in oxygen
consumption in hypothermic conditions (3). Besides
the metabolic reduction accomplished by
hypothermia, myocardial protection must also be
supported by the pharmacological arrest of the heart
in diastole via cardioplegic solutions because of the
necessity of minimizing energy production and to
reduce the effects of ischemic damage on the
myocardium.
The controversy about the most convenient choice
of the cardioplegic solution in adults seems to be
solved. Cold blood cardioplegia (CBC) applied after
the clamping of the aorta (single shot) or
administered repetitively (multi dose) and TWBC
infused before unclamping of the aorta together is
accepted to be the best choice for myocardial
protection in adults with respect to the additional
protective effects of TWBC to the CBC such as
limitation in the reperfusion injury thereby improving
the delivery of oxygen and stored cellular energy
products to the arrested myocardium and vitally
important washout of the anaerobic metabolic
products to supply a better means to preserve
phosphorilated energy products (1,4,5). However,
because of the structural, functional, and biochemical
differences between mature and immature
myocardium, adult cardio-protective strategies should
not be adopted in pediatric practice. In immature
hearts, this cardioplegia technique has been shown to
be of greater effect in myocardial protection by a few
experimental animal studies (6-8) whereas it has only
rarely been used in human pediatric patients (9,10).
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The superiority of CBC+TWBC to the other types
of cardioplegic procedures is proved to be especially
for cyanotic pediatric patients because of their
intolerance to ischemia. Although CBC,
CBC+TWBC, and CBC+ TWBC+ substrate
enhancement usage is gradually expanding among the
pediatric cardiac surgeons all over the world, CCC is
still the most commonly used procedure by pediatric
cardiac surgeons because of its ease of use (11). In
acyanotic pediatric patients, especially with short
cross clamping time, the method of cardioplegia
procedure appears not to be critical (9,12).
We use CCC to achieve the protection of
myocardium for congenital cardiac patients in our
clinic but planned to improve the myocardial
protective effects of CCC by the addition of TWBC
thereby reducing the detrimental effects of the
reperfusion injury so that the aim of this study is to
assess myocardial protective performance of CCC in
combination with TWBC in acyanotic congenital
cardiac patients.
Materials and methods
Twenty acyanotic congenital cardiac patients
admitted to the Cardiovascular Surgery Department
of Hacettepe University, Ankara, between December
2004 and April 2005 were selected for this study.
The study was approved by the Institutional
Review Board of the Medical Faculty of the University.
Patients were recruited to the study after the written
informed consents were obtained from their parents.
They were randomly allocated into 2 groups of 10
patients, in order to observe differences in myocardial
protection. Myocardial protection was performed by
moderate hypothermia (20-28°C), topical cooling and
antegrade CCC [(30 mL/kg, 4 °C) St Thomas I
crystalloid cardioplegia; 20 mmol/L KCl, 16 mmol/L
MgCl2, 2.2 mmol/L CaCl2, 144 mmol/L NaCl, and 1.0
mmol/L procaine HCl] applied after cross clamping
of the aorta in the first group. In the second group, in
addition to CCC, TWBC [(35 °C, 10 mL/kg) 4:1
dilution blood/St Thomas I crystalloid cardioplegia]
was administered just before the unclamping of the
aorta.
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Patient mopulation
Preoperative patient characteristics with respect to
age, body weight, sex, mean pulmonary artery
pressure, and the pathologies of the patients were
similar in the groups (Table 1).
Technique of cardiopulmonary bypass and
myocardial protection
After heparinization (3 mg/kg) and controlling
activated clotting time, CPB was initiated using
ascending aorta and bicaval venous cannulation.
Moderate hypothermia was performed in each group.
In the CG (30 mL/kg, 4 °C) the cardioplegic solution
was infused after the cross clamping of the aorta, in
order to achieve the diastolic cardiac arrest. The
solution was infused antegrade through an aortic root
cannula, established while topical cooling by ice slush
was performed in this group.
In the TWBCG, TWBC (10mL/kg, 35 °C) was
infused in addition to CCC solution, just before the
unclamping of the aorta. There was no topical cooling
in this group.
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In both groups, the aortic root pressure was
measured during cardioplegic delivery and was held
in the range of 40-60 mmHg. Defibrillation was
performed when ventricular fibrillation occurred
after the release of the cross clamp of the aorta.
Weaning from CPB was accomplished if systolic
blood pressure was not below 50-70 mmHg, urine
output was adequate and nasopharyngeal temperature
was 37 °C.
Anesthetic procedure
Patients were premedicated with a 0.1 cc/kg
combination of Pethidine HCl, Pheniromine
hydrogen maleate, and Chlorpromazine just an hour
before the operation. Anesthesia was induced by
Fentanyl Citrate and patients were mechanically
ventilated after the administration of Cisatracurium
besylate. Sefazolin and Gentamicin sulfate were given
routinely. Anesthesia was perpetuated by Sevoflurane
after cardiopulmonary bypass (CPB). As soon as the
operation was ended, patients were transported to the
intensive care unit (ICU) and weaned when all the
extubation criteria were obtained.

Table 1. Patient characteristics.

Age (month)
mean
range
Sex (M/F)
Weight (kg)
mPAP
Pathology
ASD
VSD
VSD, PDA
SM
VSD, PFO
VSD, SM
ASD, PAPVD
VSD, PDA, SM
ASD, VSD, MR

CG

TWBCG

P value

35.1 ± 26.04
7-96
6/4
13.0 ± 5.8
29.75 ± 13.96

54.7 ± 60.02
4-168
4/6
14.0 ± 11.5
35.3 ± 16.83

P > 0.05

4
0
1
0
1
1
1
1
1

3
4
1
1
1
0
0
0
0

P > 0.05
P > 0.05

mPAP, mean pulmonary arterial pressure; ASD, atrial septal defect; VSD, ventricular
septal defect; PDA, patent ductus arteriosus; SM, subaortic membrane; PFO, patent
foramen ovale; PAPVD, partial anomalous pulmonary venous drainage; MR, mitral
regurgitation.
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Evaluation of the clinical results before and after
the surgery
Clinical parameters included patients on whom
right ventriculotomy was performed, the duration of
CPB and aortic cross clamp, heart beat recovery after
the release of the aortic cross clamp, either
spontaneously or by electrical defibrillation and
intraoperative requirement of (+) inotropes for
weaning patients from CPB. Postoperative parameters
included the initiation, duration, and the maximum
doses of (+) inotrope dopamine, ventilation time,
intensive care unit and hospital stay, also the mortality
rate.
Measurements
Serum concentrations of TnT, CK-MB, and lactate
were determined prior to the operation, just after the
release of the aortic cross clamp, and 4, 12, 24, and 48
h postoperatively. Blood lactate concentrations were
analyzed using P modular-p 800 (Roche Diagnostics,
Indianapolis, Indiana, USA), whereas TnT and CKMB assays were performed on an Elecsys-2010
platform (Roche Diagnostics).
Conventional thresholds for the diagnosis of TnT,
CK-MB, and lactate levels are 0.0-0.1 ng/mL, 0.0-5.0
ng/mL, and 4.5-19.5 mg/dL, respectively.
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between both groups were calculated with the MannWhitney U test. A P-value of <0.05 was chosen to
define statistical significance. The statistical analysis
was performed with the Stat View software package
(Abacus Concepts, Inc., Berkeley, CA, USA).
Results
Clinical outcome
There were no significant differences between the
groups in the evaluation of the collected data. Right
ventriculotomy was performed for one patient in each
group when it was not possible to gain optimum sight
of the ventricular septal defect (VSD) through the
right atriotomy. Duration of CPB and aortic cross
clamp were both longer in TWBCG than CG but no
significant differences were observed. Electrical
defibrillation when ventricular fibrillation occurred
after the release of the cross clamp was necessary for
1 patient in TWBCG and 2 in the CG. It was not
necessary to initiate (+) inotropes during the weaning
period from CPB. The results are shown in Table 2.
Ventilation time, intensive care unit, and hospital stay
parameters showed no significant differences between
the groups, and there were no mortalities in either
group (Table 3).
Laboratory parameters

Statistical analysis
Data are presented as mean values ± standard
deviation. Testing of demographic variables was
compared by unpaired t-test. Differences of variables

Troponin T
Increasing values of serum TnT were apparent
until 4 h postoperatively. Parameters of serum TnT in

Table 2. Intraoperative variables.
CG
(n = 10)
Right ventriculotomy

TWBCG
(n = 10)

P value

1

1

P > 0.05

CPB

54.7 ± 16,17

63.2 ± 24.7

P > 0.05

ACC

35.30 ± 14.25

44.5 ± 22.26

P > 0.05

Spontaneous heart beat
recovery after ACC

8

9

P > 0.05

(+) inotropes during the
weaning period from CPB

0

0

Data are presented as mean values ± standard deviation. A P value of <0.05 was chosen
to define statistical significance. CPB, cardiopulmonary bypass; ACC, aortic cross clamp
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Table 3. Postoperative findings.
CG
(n = 10)
Duration of (+) inotropes (hour)
Ventilation support (hour)

TWBCG
(n = 10)

P value

130

93

P > 0.05

8.30 ± 4.40

9.00 ± 6.18

P > 0.05

ICU stay (day)

2.6 ± 0.7

2.9 ± 1.2

P > 0.05

Hospital stay (day)

8.2 ± 5.92

6.9 ± 1.37

P > 0.05

Data are presented as mean values ± standard deviation. A P value of < 0.05 was chosen
to define statistical significance. ICU, intensive care unit.
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CK/MB (12h)

50
25

Figure 2. Serum concentration of CK-MB levels. All results are
shown as mean values ± standard deviation. A P value
of <0.05 was chosen to define statistical significance.
CK-MB (ng/mL).

6
TWBC
CCC

5

TWBC
CCC

CK/MB (4h)

CK-MB serum levels were higher in the CG than
the TWBCG after release of the cross clamp. CK-MB
levels continued to increase to 4 h postoperatively in
both groups, minimally more in TWBCG than CG.
The downward slope of CK-MB levels initiated after
4 h and went on till 48 h postoperatively (Figure 2).

225
200

CK/MB (Clamp)

CK-MB

250

CK/MB (preop)

the CG displayed an increasing rate higher than the
TWBCG. Serum TnT values began to decrease after
4 h to 24 h postoperatively, in both groups. A slight
raise existed in CG whereas the decreasing period
went on in TWBCG, but there were no significant
differences (Figure 1).

Lactate

4

The results of serum lactate levels at the time of
unclamping of the aorta were high in both groups,
being slightly higher in the TWBCG. After 4 h, lactate
levels of CG showed a curve higher than TWBCG,
especially between 24 and 48 h but demonstrated no
significant differences (Figure 3).

3
2

T (48h)

T (24h)

T (12h)

T (4h)

T (preop)

0

T (Clamp)

1

Figure 1. Serum cardiac TnT levels. Data are presented as mean
values ± standard deviation. A P value of <0.05 was
chosen to define statistical significance. Troponin T
(ng/mL).

Discussion
Post-ischemic reperfusion-induced injury is a
paradoxical extension of ischemic damage that occurs
during reperfusion after myocardial ischemia (13). If
a reperfusion injury occurs, it may contribute to
troublesome arrhythmias, impaired cardiac
891
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The advantages of TWBC applied after a single
shot or multi-dose repetitive cold blood cardioplegia
are demonstrated in recent studies with encouraging
clinical results, showing that this myocardial
protective procedure is expanding all over the world
(6,7,9,10).

50
45

TWBC
CCC

40
35
30
25
20
15

L (48h)

L (24h)

L (12h)

L (4h)

L (Clamp)

L (preop)

10
5
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Figure 3. Serum concentration of lactate levels. Data are
presented as mean values ± standard deviation. A P
value of <0.05 was chosen to define statistical
significance. Lactate (mg/dL).

performance developing immediately after the
operation, and to the eventual myocardial fibrosis that
may result after even a perfect surgical correction of
congenital or acquired cardiac diseases (14,15). This
potential for reperfusion injury may exist after all of
the cardiac operations where coronary circulation is
interrupted by cross clamping of the aorta. To deal
with reperfusion injury is considered to be the main
object of a myocardial protective procedure, especially
in infants undergoing corrective surgery (16).
TWBC has begun to be used to reduce the
detrimental effects of reperfusion injury. It is
specifically formulated for this purpose and its
composition is vastly different from the cardioplegic
solution used for maintaining myocardial arrest
(1,17).

Even though CCC is still the most common
procedure for myocardial protective techniques in
congenital cardiac surgery, there is no study in the
literature that evaluates its performance in
combination with TWBC.
Our results showed no significant differences
between the 2 described myocardial protection
methods. Although we expected the results to be
better in the TWBC group, this was not the case.
However, serum TnT and CK-MB levels, which may
indicate a marker for myocardial injury, showed a
lower curve tendency in the TWBC than in the CG,
although not in a significant way. Increasing values of
serum lactate is one of the most significant predictors
of dangerous levels of the anaerobic metabolism,
acidosis, and the threat of dysfunction to the heart.
However, the lactate levels are not specific markers for
heart damage if they are taken systemically rather
than directly from the coronary sinus. This is one of
the main limitations of our study. The small number
of patients in this study is also an important drawback
for the statistical analysis of the results. Although we
were unable to demonstrate the advantages of TWBC
in this randomized study, more extensive research in
this area is needed with a greater number of patients.
Since this study is limited to acyanotic infants who
may have decreased ischemic cardiac injuries
compared to cyanotic and older patients with a variety
of cardiac diseases, the findings are not clear enough
to suggest any changes in the protective myocardial
management techniques.
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